Bristol-Myers Squibb Company
Acronym: BMS
General Information
Identification Code: 04437556781-76
Website: [object Object]
Entity Form: Corporation
Registration Category: Companies & groups
Registration Date: 9/26/2011
Last Update: 2/27/2024
EP Accredited Number: 9
Mission & Interests
Goals: Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Business and industry
- Competition
- Consumers
- Customs
- Digital economy and society
- Economy, finance and the euro
- Environment
- External relations
- Institutional affairs
- International co-operation and development
- Public health
- Research and innovation
- Single market
- Taxation
- Trade
Levels of Interest:
- global
Activities
Main EU Legislative Proposals: Implementation of the Pharmaceutical Strategy for Europe (including Regulation 2023/0131 for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency and Directive 2023/0123 on the Union code relating to medicinal products for human use), Fees payable to the European Medicines Agency, Revision of the OMP and Paediatric Regulations, implementation of the EU Regulation on HTA, Clinical Trials legislation, Europe's Beating Cancer Plan, Regulation on a European Health Data Space, Access to medicines, Standards of quality and safety for substances of human origin intended for human application, IP Action, Plan, EU Reference networks, cross-country collaboration on pricing and access to medicines, European Semester, trade agreements, Transatlantic Data flows, GDPR, data analytics including AI, a new transatlantic agenda, Healthier Together (EU NCD Initiative)
Communication Activities: BMS is a member and main sponsor of the All.Can initiative https://www.all-can.org/about-us/
Towards sustainable Cancer Care : Reducing Inefficiencies, improving outcomes - A policy Report from the All.Can initiative - January 2017
Blood and Beyond https://bloodandbeyond.com/
including launch event held on Thursday, March 26, 2020 and report on "Rethinking Blood Use in Europe to Improve Outcomes for" published on March 26, 2020
Cardiomyopathies Matter cardiomyopathiesmatter.org
Including launch event on November 15, 2022 in the European Parliament and report published the same day.
BMS EU Policy Twitter handle (@BMS_EUpolicy) and BMS EU policy website (www.eupolicy.bms.com) launched in January 2023
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: Park Avenue, 345
Post Code: 10154
City: New York, NY
Country: UNITED STATES
Phone: [object Object]
EU Office
Address: Rue du Trône 108
Post Code: 1050
City: Ixelles
Country: BELGIUM
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Complementary Information: Bristol-Myers Squibb Belgium has a corporate sponsorship with the Alliance of Liberals and Democrats for Europe for 2023. The amount of that corporate sponsorship is 18,000 euros and it is treated as a political donation.
Membership Information
Members10 Percent: 3
Members25 Percent: 2
Members50 Percent: 2
Members75 Percent: 1
Members: 10
Members F T E: 4.550000190734863
Info Members: 1 Head of International Policy and Government Affairs (10%)
1 Senior Director, EU Government Affairs Strategy and Excellence (90%)
1 Director European Government Affairs (50%)
1 Associate Director, European Public Policy (90%)
1 Director, Government Engagement and Partnerships, Europe (50%)
1 Director, International Government Affairs Excellence (10%)
1 Associate Director, Policy & Government Affairs - Intercontinental (10%)
1 Senior Director, Health Policy, Strategy and Economics (25%)
1 Senior Director, Global Policy Partnerships & Alliance Development (10%)
1 Director, International Policy Communications (50%)
Other BMS employees contributing to EU policy-shaping through participation in trade association working groups are accounted for in the total expenses, but not in the FTE above. The above covers only Brussels-based policy & government affairs staff.
Structure
Structure Type: Structure
Is Member Of: See above
Organisation Members: European Federation of Pharmaceutical Industries and Associations (EFPIA), EFPIA Oncology Platform, EFPIA Cardiovascular Health Platform, DigitalEurope, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), Friends of Europe, American Chamber of Commerce to the EU, American European Community Association (AECA), American Chamber of Commerce Turkey, European Patients' Forum, EURORDIS, TRANSFORM Alliance